Heather Bresch, the former president and CEO of the drugmaker Mylan, worked directly with the CEO of Pfizer to keep prices of the company’s EpiPen product artificially high, according to new documents ...
The daughter of a U.S.senator and Mylan CEO Heather Bresch recently said that the $500 increase in the cost of the life-saving EpiPen since she has taken over as CEO is not to blame on her.
Heather Bresch, CEO of pharmaceutical company Mylan, appeared before the US government’s House Oversight and Government Reform Committee two weeks ago. In a hearing over the price of her company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results